The US National Community
Pharmacists’ Association has
expressed concerns about a
proposals circulating in response
to the recent series controversies
where several compounding
pharmacies have been shut down.
Some lawmakers have suggested
granting the US Food and Drug
Administration unrestricted
authority over a ‘do not
compound’ list, which the NCPA
says could impact patient access
to compounded medication such
as hormone treatments, thyroid
preparations & promethazine gels.
Another proposal would see
pharmacies required to notify
the FDA when compounding
medications are in short supply.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Jul 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Jul 13
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.